Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2025-07-01 Sale | 2025-07-02 5:28 pm | Travere Therapeutics Inc. | TVTX | Inrig Jula CHIEF MEDICAL OFFICER | 815 | $14.65 | $11,940 | 88,787 (Direct) | View |
| 2025-02-12 Sale | 2025-02-12 9:22 pm | Travere Therapeutics Inc. | TVTX | Inrig Jula CHIEF MEDICAL OFFICER | 2,568 | $23.53 | $60,426 | 89,602 (Direct) | View |
| 2025-02-03 Sale | 2025-02-04 8:30 pm | Travere Therapeutics Inc. | TVTX | Inrig Jula CHIEF MEDICAL OFFICER | 5,273 | $20.12 | $106,082 | 184,170 (Direct) | View |
| 2025-01-03 Sale | 2025-01-06 7:21 pm | Travere Therapeutics Inc. | TVTX | Inrig Jula CHIEF MEDICAL OFFICER | 2,506 | $19.04 | $47,715 | 59,443 (Direct) | View |
| 2024-09-10 Sale | 2024-09-10 4:05 pm | Travere Therapeutics Inc. | TVTX | Inrig Jula CHIEF MEDICAL OFFICER | 684 | $12.98 | $8,878 | 61,949 (Direct) | View |
| 2024-09-09 Sale | 2024-09-09 9:20 pm | Travere Therapeutics Inc. | TVTX | Inrig Jula CHIEF MEDICAL OFFICER | 2,191 | $11.52 | $25,240 | 62,633 (Direct) | View |
| 2024-02-01 Sale | 2024-02-02 4:05 pm | Travere Therapeutics Inc. | TVTX | Inrig Jula CHIEF MEDICAL OFFICER | 2,174 | $8.5311 | $18,547 | 149,074 (Direct) | View |
| 2024-01-03 Sale | 2024-01-05 4:11 pm | Travere Therapeutics Inc. | TVTX | Inrig Jula Chief Medical Officer | 2,509 | $9.4251 | $23,648 | 35,248 (Direct) | View |
| 2023-01-04 Sale | 2023-01-06 4:05 pm | Travere Therapeutics Inc. | TVTX | Inrig Jula Chief Medical Officer | 2,493 | $20.75 | $51,730 | 17,507 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2025-02-10 Exercise | 2025-02-12 9:22 pm | N/A N/A | Travere Therapeutics Inc. | TVTX | Inrig Jula CHIEF MEDICAL OFFICER | 8,000 | $0 | 89,602 (Direct) | View |
| 2025-01-31 Option Award | 2025-02-04 8:30 pm | N/A 2035-01-31 | Travere Therapeutics Inc. | TVTX | Inrig Jula CHIEF MEDICAL OFFICER | 130,000 | $0 | 184,170 (Direct) | View |
| 2024-09-05 Option Award | 2024-09-09 9:20 pm | N/A N/A | Travere Therapeutics Inc. | TVTX | Inrig Jula CHIEF MEDICAL OFFICER | 6,750 | $0 | 62,633 (Direct) | View |
| 2024-01-31 Option Award | 2024-02-02 4:05 pm | N/A 2034-01-30 | Travere Therapeutics Inc. | TVTX | Inrig Jula CHIEF MEDICAL OFFICER | 116,000 | $0 | 149,074 (Direct) | View |
| 2023-01-31 Option Award | 2023-02-02 7:00 pm | N/A 2033-01-30 | Travere Therapeutics Inc. | TVTX | Inrig Jula Chief Medical Officer | 81,500 | $0 | 99,007 (Direct) | View |
| 2022-01-31 Option Award | 2022-02-02 4:20 pm | N/A N/A | Travere Therapeutics Inc. | TVTX | Inrig Jula Chief Medical Officer | 8,000 | $0 | 8,000 (Direct) | View |
| 2022-01-01 Option Award | 2022-01-04 6:09 pm | N/A 2032-12-31 | Travere Therapeutics Inc. | TVTX | Inrig Jula Chief Medical Officer | 100,000 | $0 | 100,000 (Direct) | View |